CABOZANTINIB TABLETS 20 / 80 MG
For the treatment of patients with advanced renal cell carcinoma (RCC). For the treatment of patients with Hepatocellular Carcinoma (HCC) who have been previously treated with sorafenib.
Note: Products are not marketed in countries where it is protected by Patent Law
Enter your name and email to download PDF.
Thanks, I’m not interested